corman said...
I was wondering about PSA after radiation especially external beam...
Hi Glenn,
The American Urological Association (AUA) document titled Prostate Specific Antigen Best Practice Statement: 2009 Update has an excellent response to your question regarding PSA after external beam radiation.
I've made the title a link to the free online AUA document (check page 39), and have quoted a few relevant lines here for easy reference:
-
Serum PSA should fall to a low level following radiation therapy...and should not rise on successive occasions.
-
Following radiation therapy, the PSA value should fall to a low level and then remain stable.
-
PSA values <0.2 are uncommon after external beam radiotherapy, which does not ablate all prostate tissue.
-
A consistently rising PSA level usually, though not always, indicates cancer recurrence.
-
The number of rises needed to define a failure has been a matter of debate, but a consensus is emerging in support of the American Society for Therapeutic Radiation and Oncology (ASTRO) definition of failure: three successive rises above nadir.
-
More recently it has been recognized that this endpoint is relevant only for external beam radiotherapy and even then it is easily confounded by biological variability.
-
A Consensus Committee was convened in Phoenix in 2005 to reconcile these differences [discussion of PSA results after brachytherpy and external beam] and to produce a universal definition of PSA failure after all forms of radiation therapy, with or without androgen deprivation. The Committee arrived at the following conclusions: that any rise in PSA level of 2.0 ng/mL or more, over and above the nadir, predicted true failure with great sensitivity and specificity after both external beam radiotherapy and interstitial prostate brachytherapy, irrespective of whether either of these treatments was accompanied by androgen deprivation.
-
This endpoint, the “Phoenix Definition,” was designed to make comparison between any radiation series possible but did not facilitate easy comparisons with surgical series. It was designed as a research tool, rather than as a trigger for a clinical intervention.
-
The Consensus Committee further noted that setting a “target PSA” was not possible after external beam radiotherapy, although for interstitial prostate brachytherapy a PSA level of <0.7 ng/mL at five years would be reasonable.
hope this helps answer your question...